AOD 9604
Ships fully reconstituted · no mixing, no powder, no bacteriostatic waterPure Fat Burning Peptide
A growth hormone fragment engineered specifically for targeted fat metabolism.
Choose your supply
Extra 10% off your first order · use code WELCOME10 at checkout (stacks with the supply discount above).
Frequently paired with
What it supports
- Targeted fat reduction without hormonal effects
- No impact on blood sugar or IGF-1 levels
- Supports sustainable weight management
- Promotes lipolysis in adipose tissue
- Does not affect appetite or muscle mass
The details
- Administration
- Subcutaneous injection
- Format
- 3mg/mL, 5mL vial
- Typical dosing
- 250-500mcg daily
- Best for
- Targeted fat reduction
- Pairs well with
- MOTS-C, CJC-1295/Ipamorelin
- Mechanism
- AOD 9604 mimics the fat-reducing action of growth hormone without affecting blood sugar or IGF-1 levels. It stimulates lipolysis and inhibits lipogenesis, targeting fat metabolism directly.
How it works
Signal
AOD-9604 is given as a subcutaneous injection, typically in the morning, on a provider-determined schedule.
Cellular response
AOD-9604 mimics the fat-reducing action of growth hormone without affecting blood sugar or IGF-1. It stimulates lipolysis and inhibits lipogenesis, targeting fat metabolism directly while sparing lean muscle.
Outcome
Over the following weeks most people notice subtle metabolic shifts and reduced bloating first (weeks 1–2), then more noticeable body-composition change around the midsection (weeks 2–4), then visible fat loss with muscle preserved (weeks 4–8), with the best results from week 8 onward — diet and exercise still do the heavy lifting.
Sources & references
Fat reduction without growth effects
Heffernan MA et al. Obes Res. 2001;9(12):813–819.
View sourceHuman clinical trial
Stier H et al. J Endocrinol Metab. 2004.
View sourceGRAS safety assessment
Stier H et al. Regul Toxicol Pharmacol. 2015;72(2):358–364.
View sourceAOD-9604 in human osteoarthritis trials
Drug Design, Development and Therapy, 2015
View sourceLipolytic mechanism of the GH 177-191 fragment
Endocrinology, 2001
View sourceCartilage regeneration with AOD-9604
Cartilage, 2016
View sourceSafety of GH fragment peptides in humans
Clinical Pharmacology, 2018
View source
Common questions
Important safety information
AOD 9604 is available by prescription only and is dispensed after a licensed provider reviews your medical screening and determines it is appropriate for you. Compounded medications are prepared by a licensed U.S. pharmacy and are not FDA-approved products. Tell your provider about your full medical history and any medications you take.
- • Generally well tolerated
- • Possible injection site reactions
- • Should not be used during pregnancy
- • Requires licensed provider supervision